Christopher J. Harvey

3.9k total citations
46 papers, 2.7k citations indexed

About

Christopher J. Harvey is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher J. Harvey has authored 46 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Immunology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher J. Harvey's work include Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Christopher J. Harvey is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Christopher J. Harvey collaborates with scholars based in United States, United Kingdom and Canada. Christopher J. Harvey's co-authors include Shyam Biswal, Rajesh K. Thimmulappa, Aleksandr B. Stefaniak, Anju Singh, Thomas Albrecht, D S Kumararatne, Carmel B. Stober, Sandra Panchalingam, David A. Lammas and Nancy C. Kendrick and has published in prestigious journals such as Science, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Christopher J. Harvey

43 papers receiving 2.7k citations

Peers

Christopher J. Harvey
Yan Zhang China
Dandan Li China
John H. Fechner United States
Xinran Li China
Sang Gyu Park South Korea
Yan Zhang China
Christopher J. Harvey
Citations per year, relative to Christopher J. Harvey Christopher J. Harvey (= 1×) peers Yan Zhang

Countries citing papers authored by Christopher J. Harvey

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Harvey more than expected).

Fields of papers citing papers by Christopher J. Harvey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Harvey. The network helps show where Christopher J. Harvey may publish in the future.

Co-authorship network of co-authors of Christopher J. Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Harvey. A scholar is included among the top collaborators of Christopher J. Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Harvey. Christopher J. Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harvey, Christopher J., et al.. (2024). Traumatic chylothorax following blunt thoracic trauma. Trauma Case Reports. 54. 101101–101101. 1 indexed citations
2.
Harvey, Christopher J., Kamal Gupta, Mark Wiley, et al.. (2024). Predictors of left atrial appendage emptying velocity: Derivation and validation of CHIRP3(M-1) score. Heart Rhythm. 22(4). 923–931.
3.
4.
Harvey, Christopher J., et al.. (2021). 3D QRS AREA CALCULATION FROM X, Y, Z VECTORCARDIOGRAPHIC LEADS: AREA SUBTENDED BY NEGATIVE DEFLECTIONS SHOULD BE ADDED AND NOT SUBTRACTED. Journal of the American College of Cardiology. 77(18). 364–364. 1 indexed citations
5.
Elpek, Kutlu G., Ellen Duong, Martin Fan, et al.. (2020). ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models. PLoS ONE. 15(9). e0239595–e0239595. 23 indexed citations
6.
Andrade, Lucas Ferrari de, Rong En Tay, Deng Pan, et al.. (2018). Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity. Science. 359(6383). 1537–1542. 337 indexed citations
7.
Elpek, Kutlu G., Viviana Cremasco, Hua Shen, et al.. (2014). The Tumor Microenvironment Shapes Lineage, Transcriptional, and Functional Diversity of Infiltrating Myeloid Cells. Cancer Immunology Research. 2(7). 655–667. 64 indexed citations
8.
Biswal, Shyam, Rajesh K. Thimmulappa, & Christopher J. Harvey. (2012). Experimental Therapeutics of Nrf2 as a Target for Prevention of Bacterial Exacerbations in COPD. Proceedings of the American Thoracic Society. 9(2). 47–51. 41 indexed citations
9.
Kong, Xiaoni, Rajesh K. Thimmulappa, Florin L. Craciun, et al.. (2011). Enhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects against Sepsis. American Journal of Respiratory and Critical Care Medicine. 184(8). 928–938. 178 indexed citations
10.
Stefaniak, Aleksandr B., Christopher J. Harvey, M. Abbas Virji, & Gregory A. Day. (2010). Dissolution of cemented carbide powders in artificial sweat: implications for cobalt sensitization and contact dermatitis. Journal of Environmental Monitoring. 12(10). 1815–1815. 8 indexed citations
11.
Harvey, Christopher J., Rajesh K. Thimmulappa, Anju Singh, et al.. (2008). Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radical Biology and Medicine. 46(4). 443–453. 422 indexed citations
12.
Stefaniak, Aleksandr B. & Christopher J. Harvey. (2006). Dissolution of materials in artificial skin surface film liquids. Toxicology in Vitro. 20(8). 1265–1283. 106 indexed citations
13.
Padhani, Anwar R., Christopher J. Harvey, & David O. Cosgrove. (2005). Angiogenesis imaging in the management of prostate cancer. Nature Clinical Practice Urology. 2(12). 596–607. 43 indexed citations
14.
Harvey, Christopher J. & Martin Blomley. (2005). Imaging investigation of liver haemodynamics in patients at risk for hepatic metastatic disease. British Journal of Radiology. 78(926). 103–104. 8 indexed citations
15.
Harvey, Christopher J., Adrian Lim, Martin Blomley, et al.. (2002). Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. European Radiology. 12(S3). S70–S73. 19 indexed citations
16.
Harvey, Christopher J., Ian A. Renfrew, Stuart A. Taylor, A. Gillams, & William R. Lees. (2001). Spiral CT pneumocolon: applications, status and limitations. European Radiology. 11(9). 1612–1625. 9 indexed citations
17.
Harvey, Christopher J. & Thomas Albrecht. (2001). Ultrasound of focal liver lesions. European Radiology. 11(9). 1578–1593. 127 indexed citations
18.
Richenberg, Jonathan & Christopher J. Harvey. (1999). The utility of CT in imaging chest infections in HIV-negative patients. Current Opinion in Pulmonary Medicine. 5(3). 179–179. 4 indexed citations
19.
Harvey, Christopher J., et al.. (1999). Imaging of tumour therapy responses by dynamic CT. European Journal of Radiology. 30(3). 221–226. 36 indexed citations
20.
Lammas, David A., Carmel B. Stober, Christopher J. Harvey, et al.. (1997). ATP-Induced Killing of Mycobacteria by Human Macrophages Is Mediated by Purinergic P2Z(P2X7) Receptors. Immunity. 7(3). 433–444. 342 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026